Citi analyst Graham Parry maintained a Buy rating on Novartis AG yesterday. The company’s shares closed yesterday at CHF122.08.Introducing TipRanks MCP for Agents Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools. Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.
According to TipRanks, Parry is a 2-star analyst with an average return of 0.6% and a 59.32% success rate.
Currently, the analyst consensus on Novartis AG is a Moderate Buy with an average price target of $154.59, implying a 26.63% upside from current levels. In a report released on June 11, Bank of America Securities also maintained a Buy rating on the stock with a CHF140.00 price target.
Based on Novartis AG’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of CHF12.83 billion and a net profit of CHF3.09 billion. In comparison, last year the company earned a revenue of CHF13.62 billion and had a net profit of CHF3.61 billion
